HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of facial angiofibromas in tuberous sclerosis: use of the carbon dioxide laser.

Abstract
Facial angiofibromas are estimated to occur in 90% of patients with tuberous sclerosis and can cause considerable cosmetic disfigurement, emotional distress, obstruction of vision, and hemorrhage when abraded. Postoperative wound management associated with skin grafting and dermabrasion is often difficult because patients are mentally retarded and noncooperative. Three patients with extensive facial angiofibromas were treated successfully with the carbon dioxide (CO2) laser, with follow-up period ranging from 8 to 48 months. Uncomplicated wound healing occurred in each patient with minimal recurrence of lesions. Ablation with the CO2 laser is our treatment of choice for angiofibromas associated with tuberous sclerosis.
AuthorsG S Bellack, S M Shapshay
JournalOtolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (Otolaryngol Head Neck Surg) Vol. 94 Issue 1 Pg. 37-40 (Jan 1986) ISSN: 0194-5998 [Print] England
PMID3005944 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Carbon Dioxide
Topics
  • Adult
  • Carbon Dioxide
  • Facial Neoplasms (complications, surgery)
  • Female
  • Histiocytoma, Benign Fibrous (complications, surgery)
  • Humans
  • Laser Therapy
  • Male
  • Tuberous Sclerosis (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: